Optics.org
daily coverage of the optics & photonics industry and the markets that it serves
News
Menu
Verisante's
Verisante's "Aura" probe, shown here, is based on the same Raman spectroscopy platform as the "Core", and has been tested for a variety of cancer screening applications. The Charing Cross Hospital trial will be the first to use Raman during brain surgery. Credit: Verisante Technology.
Copyright © 2019 SPIE EuropeDesigned by Kestrel Web Services